China Shineway Pharmaceutical Group Ltd.  

(Public, HKG:2877)   Watch this stock  
Find more results for HKG: 2877
6.96
+0.04 (0.58%)
Delayed:   3:15PM GMT+8
HKG data delayed by 15 mins - Disclaimer
Currency in HKD
Range 6.91 - 7.00
52 week 6.67 - 9.86
Open 6.92
Vol / Avg. 179,000.00/693,852.00
Mkt cap 5.76B
P/E 9.84
Div/yield 0.13/3.81
EPS 0.71
Shares 827.00M
Beta     -
Inst. own     -
Oct 25, 2017
Nine Months 2017 China Shineway Pharmaceutical Group Ltd Corporate Sales Release
  

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 22.54% 29.56%
Operating margin 31.55% 34.88%
EBITD margin - 39.11%
Return on average assets 5.67% 9.34%
Return on average equity 6.48% 10.79%
Employees 3,628 -
CDP Score - -

Address

Luancheng
SHIJIAZHUANG, HEB 051430
China
+86-311-88030066 (Phone)
+86-311-88030088 (Fax)

Website links

Description

China Shineway Pharmaceutical Group Limited is an investment holding company principally engaged in the research and development, manufacture and trading of modern Chinese medicines. Its main products include injections, soft capsules and granules. The Company’s subsidiaries include Yuan Da International Limited, Hong Zhan International Limited and Shineway Pharmaceutical Sales Company Limited.

Officers and directors

Zhenjiang Li Executive Chairman of the Board, President
Age: 61
Bun Ching Lee Financial Controller, Company Secretary
Age: 44
Zhong Chen Executive Director
Age: 50
Ching Ton Lee Executive Director
Age: 34
Huimin Li Executive Director
Age: 49
Yunxia Xin Executive Director
Age: 53
Yat Hung Luk CPA Head - Investor Relation
Age: 58
Li Cheng Independent Non-Executive Director
Age: 57
Guoan Luo Independent Non-Executive Director
Age: 70
Liutai Sun Independent Non-Executive Director
Age: 53